| Names | |
|---|---|
| Preferred IUPAC name | (2S,3R)-2-Amino-3-hydroxybutanoic acid |
| Other names | (2S,3R)-2-Amino-3-hydroxybutanoic acid Threonine 2-Amino-3-hydroxybutyric acid |
| Pronunciation | /ɛl ˈθriː.əˌniːn/ |
| Identifiers | |
| CAS Number | 72-19-5 |
| Beilstein Reference | 1204077 |
| ChEBI | CHEBI:57927 |
| ChEMBL | CHEMBL1126 |
| ChemSpider | 64393 |
| DrugBank | DB00169 |
| ECHA InfoCard | 100.035.436 |
| EC Number | 2.2.1.6 |
| Gmelin Reference | 6937 |
| KEGG | C00188 |
| MeSH | D001937 |
| PubChem CID | 6288 |
| RTECS number | XS0350000 |
| UNII | 9F68G6K51Q |
| UN number | 2811 |
| Properties | |
| Chemical formula | C4H9NO3 |
| Molar mass | 119.12 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | D = 1.3 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -3.03 |
| Acidity (pKa) | 2.09 |
| Basicity (pKb) | 8.75 |
| Magnetic susceptibility (χ) | -8.2 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.527 |
| Dipole moment | 6.5671 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 100.5 J·K⁻¹·mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -889.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1273.1 kJ/mol |
| Pharmacology | |
| ATC code | A16AA04 |
| Hazards | |
| Main hazards | May cause respiratory irritation. |
| GHS labelling | GHS07, Exclamation mark |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard Statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Precautionary statements | P264, P270, P273, P301+P312, P305+P351+P338, P501 |
| NFPA 704 (fire diamond) | 1-0-0 |
| Autoignition temperature | > 406 °C (763 °F; 679 K) |
| Lethal dose or concentration | LD50 (oral, rat): > 5,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 > 5,000 mg/kg |
| NIOSH | TH9160000 |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 2,000 mg |
| Related compounds | |
| Related compounds | D-Threonine Allothreonine L-2-Aminobutyric acid Serine Homoserine |
| Section | Details | Manufacturer Technical Commentary |
|---|---|---|
| Product Name | L-Threonine | Commercial production of L-Threonine targets required purity and is focused on fermentation-derived amino acid for feed and food uses. Batch origin, fermentation organisms, and downstream purification approach influence the compositional fingerprint recognized by buyers during incoming inspection. |
| IUPAC Name | (2S,3R)-2-amino-3-hydroxybutanoic acid | This nomenclature specifically identifies the stereochemistry. Enantiomeric excess and stereospecificity are process-critical during high-purity manufacturing and define if the material meets monograph or application-based requirements. Nonconforming optical purity in feed-grade can trigger reprocessing or off-grade sale. |
| Chemical Formula | C4H9NO3 | Purity monitoring focuses on by-product control, especially alpha-keto butyrate and related amino acids, which may arise during microbial synthesis or hydrolysis. Analytical batch release confirms identity and compositional integrity for formulated downstream products. |
| Synonyms & Trade Names | Threonine, L-2-Amino-3-hydroxybutyric acid, (S)-Threonine | Synonym recognition supports supply chain traceability and regulatory acceptance. Regional trade names may reflect different specification grades (e.g., feed-grade versus pharma-grade). Manufacturer disclosure of commercial synonyms builds transparency for certificate of analysis comparison across supply chain audits. |
| HS Code & Customs Classification | 2922.49 | The HS Code 2922.49 covers amino-acids and their esters, with applications requiring declaration at customs for feed, food, and pharma. Country of origin, production route, and grade often trigger additional documentation in trade. Manufacturers aligning documentation with the proper HS class reduce risk of customs delays or reclassification penalties. |
L-Threonine’s industrial production focuses on fermentation using genetically tailored organisms, supporting consistent enantiomeric purity in the product. Feed-grade production often prioritizes yield and cost, while pharma or food requires tighter controls against microbial impurities and process-derived contaminants. Quality teams maintain identity and purity assurance by selecting high-quality nutrient feedstock and limiting exposure to foreign amino acids in fermentation, which affects cross-contamination risks and batch clearance speeds.
Highly specific process controls govern impurities such as moisture, ash, and residual nutrients. The choice between continuous and batch process routes determines the impurity profile. Scale-up for industrial capacity relies not just on fermentation optimization, but also on final purification and drying control to reach commercially acceptable bulk density and particle flow for downstream blending.
For compliance in global trade, aligning HS code declarations and maintaining detailed records of grade-specific features help prevent misclassification. Customs authorities frequently audit documents, and gaps in the traceability chain raise costs or prompt border rejection. Product stewardship by the manufacturer strengthens customer confidence and market access, minimizing disputes and facilitating process validation for animal nutrition, human food fortification, and specialty chemical synthesis applications.
L-Threonine is encountered as a crystalline solid, typically white or off-white, with no distinct odor. The form, color, and purity largely reflect both the production route and subsequent purification stage. Highly refined grades show minimal coloration, while technical grades may display slight color variation due to minor byproduct retention. Melting and boiling points are strongly grade-dependent as small residual water or unreacted substrate influence observed ranges. Production-scale batches occasionally show marginal differences in crystal habit and flow due to varying seed crystal techniques or drying regimes.
L-Threonine demonstrates good stability under normal handling and storage temperatures for shipment and downstream processing. Reactivity can arise when mixed with strong oxidizers or acids, particularly in the presence of elevated moisture or thermal input. Lower-grade material may be more susceptible to decomposition or browning if trace metallic or organic impurities remain from upstream bioprocessing or chemical synthesis steps.
Fully-dried, high-purity L-Threonine has good solubility in water, a critical parameter for feed, food, and pharmaceutical customers. Solubility can vary depending on particle size, agglomeration state, and presence of hydrophilic or hydrophobic byproducts. In plant operation, monitoring solution clarity and pH during dissolution offers a practical proxy for assessing purity and impurity carryover. For technical solution preparation, batch-to-batch consistency checks are made to avoid precipitation or unwanted gel formation in downstream blending or formulation tanks.
Specifications for L-Threonine depend sharply on whether the grade targets animal feed supplementation, food fortification, or pharmaceutical active ingredient use. Typical values for assay, moisture, residue on ignition, and heavy metals content shift as customer class changes. Feed and technical grades focus on macronutrient guarantee with looser impurity cutoffs, while food and pharma grades require tighter control for lead, arsenic, endotoxin, and bioburden. Exact specification data remains proprietary or is defined by mutual agreement upon order placement.
| Parameter | Feed Grade | Food/Pharma Grade |
|---|---|---|
| L-Threonine (dry basis) | Typical min. value, application-set | Defined by regulatory limits |
| Moisture | Lower control limits (process-specific) | Strict upper bounds (region/customer-required) |
| Heavy Metals | Monitored, less stringent | Stringent, batch release required |
| Microbial Load | Screened, batch traceable | Tested per pharma compendium |
Profile of organic and inorganic impurities is primarily a function of the production route and purification depth. By-products from fermentation (e.g. residual sugars, organic acids) or chemical synthesis (e.g. excess reagents, side-chain isomers) must be characterized and monitored. Control strategies include targeted removal of known impurities and thorough cleaning validation for cross-batch consistency. Regulatory filings or customer contracts define specifically managed impurity classes and quantitative limits, with typical variations across geographies.
Assay, identity, and impurity testing rely on validated chromatographic, spectrophotometric, and wet chemistry protocols suitable for product grade. USP, FCC, or in-house methods may apply depending on customer segment and delivery region. Routine tests include amino acid analyzer quantitation, IR/NMR confirmation, and trace metal quantification by ICP. Consistent method suitability trials and proficiency cross-checks underpin every batch release.
Fermentation-derived L-Threonine plants source carbohydrate feedstocks (corn, cane, wheat hydrolysate) and certified GRAS microbial strains for primary synthesis. Chemical synthesis lines necessitate high-purity L-aspartic acid and derived intermediates as well as catalyst and solvent supplies. Supplier reliability and contaminant control are scrutinized through regular auditing and incoming lot testing. Sourcing contracts account for regional variability in raw material GMO status, allergenic risk, and pesticide carryover, which can influence final quality profile.
Major industrial L-Threonine production employs biocatalytic fermentation with genetically-optimized E. coli or Corynebacterium lines, owing to their productive titer and established downstream processing knowledge. Alternative chemical synthesis from aspartic acid or via resolution of racemic synthetic threonine remains in use for specialized markets requiring enantiopure or custom-derivative supply. Route selection pivots on considerations of yield, impurity burden, recoverability, and capital intensity.
Process design centers on cell growth control, in-batch product titer monitoring, and removal of fermentation byproducts post-harvest. Process-critical parameters include fermentation temperature, pH, oxygenation, and antifoam addition. Harvested broth undergoes clarification, decolorization, ion-exchange, and crystallization, followed by multiple drying and sieving stages based on customer specs for particle sizing. Purification logic rests on maximizing product recovery while depleting microbial, ionic, and organoleptic impurities to grade-appropriate levels. Regular in-process monitoring (e.g. HPLC, conductivity, color index) ensures batch trajectory aligns with expected output standards.
Finished goods release depends on full analytical confirmation against internal and contractual standards. Quality control teams review assay, impurity, residual moisture, color, microbial, and physical form data. Out-of-trend parameters prompt investigative correction at either upstream fermentation or downstream purification stages. Final release reflects compliance with regional, customer, and legal requirements. Batch numbering and traceability documents enable recall or audit response capability, as necessitated by GMP/GDP frameworks.
L-Threonine’s functional groups – primary amino and secondary hydroxyl – determine the reactive pathways available for chemical derivatization. Amidation, esterification, and acylation are among the transformations leveraged for intermediate generation in peptide synthesis or fine chemical modification.
Reactions involving the amine or hydroxyl moieties use acid chlorides or anhydrides with appropriate base scavenging, typically under mild to controlled temperature and solvent conditions. Direct modification can create unwanted byproducts if residual process impurities remain or moisture is uncontrolled during reaction setup.
Commercial L-Threonine grades serve as a core building block for peptide medicines, food supplements, and customized amino acid derivatives (e.g., O-acyl threonine esters, protected threonine analogs). The ability to achieve efficient downstream conversion relies on predictable impurity profiles, high chemical purity, and reliable batch traceability.
Material integrity is best retained at cool, controlled temperatures under low humidity and minimal light exposure. Container selection varies by grade, with food and pharma applications relying on high-barrier bags or drums to reduce moisture ingress and oxidative exposure. Feed and technical grades typically ship in multiwall kraft or PE-lined sacks, with user storage feedback guiding container evolution.
Packing system must prevent migration of plasticizers or off-odors from packaging to product. Incompatibility leads to off-spec aroma or color, posing risk to end-use application or tradition-sensitive customers.
Degradation in bulk storage presents as yellowing, agglomeration, caking, or the development of atypical odors, tied to oxidation, hydrolysis, or microbial action. Shelf life claims are always conditional on the packaging type, storage temperature, and downstream usage rate. Accelerated stability protocols support specification justification but may be revised according to market feedback and complaint trending.
Hazard communications follow internal safety data and globally harmonized system (GHS) rules. L-Threonine is generally classified as non-hazardous for acute exposure, but production facilities treat all amino acid powders as dust explosion capable and enforce respiratory control in open handling zones.
Main hazards in industrial facilities involve dust inhalation, eye/cutaneous contact, and mechanical handling of large quantities. Operators wear protective coveralls, gloves, eye protection, and respirators where dust levels may surge, particularly during bag opening or bulk transfer. Emergency protocols for accidental spill focus on dust suppression and dry containment, not aqueous cleanup, to prevent slip and uncontrolled fermentation risk.
Toxicity concerns arise from chronic, not acute, exposure and are largely negligible at industrial exposure levels for healthy adult workers. Detailed exposure data is periodically reviewed to reflect changes in production scale, impurity loading, and regulatory landscape. Facility medical staff and safety teams monitor workplace health metrics as part of routine occupational hygiene programs.
No consensus occupational exposure limit exists globally, but internal risk management enforces precautionary thresholds as set out by internal safety committees and local legislation. Material movement through the facility follows engineered containment strategies, including closed transfer systems, local dust extractors, and zone-based access controls to minimize cross-contamination risk and worker exposure.
Annual supply ability for L-Threonine directly ties to both fermentation line throughput and raw substrate procurement. Large-volume output depends on sustained access to qualified carbohydrate feedstocks, nutritional supplements, and process water for microbial synthesis. Output capacity can fluctuate seasonally, as industrial maize, cassava, or cane sugar yields affect input stocks and price. For pharmaceutical and feed grades, market availability responds to both planned capacity expansions and scheduled maintenance at major global production hubs. Short-term disruptions usually trace to bioreactor downtime, raw material shipping delays, or purification bottlenecks.
Typical order-to-shipment lead time varies with batch scheduling, customer qualification protocols, and downstream processing line speed. Feed additive and standard grade L-Threonine often offers shorter availability windows, as demand forecasting is smoother, and batch sizes are larger. Minimum order quantities (MOQ) depend on grade, packaging format, and specific customer audit requirements. Lower MOQs usually carry premium pricing reflecting non-standard processing and partial line load.
Package selection affects both supply chain logistics and risk of cross-contamination. Feed grade commonly ships in multi-layered kraft paper bags with polyethylene liners, emphasizing moisture barrier for bulk users. Pharmaceutical and food grades may require food-contact approval, tamper-evident closures, or custom serialization for traceability. Non-standard unit weights, palletized or containerized loads, and anti-caking liners are applied to meet specific downstream machinery or regulatory demands.
Shipping terms depend on customer geography, order volume, and existing logistics arrangements. Typical terms include FCA, FOB, or CIF to major port facilities. For regulated markets, full batch documentation and CoAs travel with shipments. Payment terms often reflect buyer credit history and total annual commitment. Letters of credit, advance payment, and net terms are set during annual contract negotiations or framework agreements.
Production cost for L-Threonine primarily follows carbohydrate substrate markets. Corn, wheat, or cassava pricing swings transfer rapidly to amino acid manufacturing economics. Key cost drivers also include fermentation nutrient solution price, energy input for aeration and agitation, and downstream purification consumables. Bioprocess yield and titer improvement initiatives reduce marginal cost but face technical constraints tied to strain genetics and impurity control.
The most direct cost fluctuations result from feedstock volatility. Regional drought stresses or commodity speculation impact carbohydrate supply chains. In regions with heavy energy subsidy adjustments or industrial utility rationing, process energy costs jump, pushing final price levels. Fermentation performance events, such as bio-contamination or yield drops, cause short-term spikes, especially in periods without significant product overstock.
Price differentiation is determined by grade purity, impurity profile, and compliance documentation. Feed grade commands lowest per-kilogram price due to relaxed limits on certain trace contaminants. Food or pharmaceutical grade requires additional purification, certified allergens absence, and full traceability—from raw material intake through to finished packing. Audit infrastructure, quality assurance programs, and mandatory third-party testing increase cost base and commercial price.
Purity targets change by application: feed use typically accepts lower thresholds for fermentation byproducts or trace metals; pharmaceutical routes restrict even sub-ppm contamination, requiring additional isolation and analytical validation. Packaging certification and regulatory labeling obligations increase premium on higher grades. Markets requiring Kosher, Halal, or custom compliance labeling pay higher unit rates due to both batch segregation and documentary control costs.
Overall capacity for L-Threonine has expanded as dietary protein substitutes and intensive livestock operations seek alternatives to traditional sources. Market demand aligns with animal feed, premix manufacturers, and pharmaceutical excipient markets. Supply risks depend on bio-based feedstock harvest cycles and regional processing capacity. Key economies closely monitor this product’s supply chain resilience due to critical use in food security and public health strategies.
Production leadership remains with East Asian producers, especially in China, where integrated supply chains and flexible production lines dominate global export activity. The United States and European Union represent major consumption zones, with regulatory oversight and pharmaceutical excipient requirements setting stricter purity standards. Japan maintains a legacy of high-quality small-batch production, mainly consumed domestically. India’s expanding animal nutrition sector points to growing domestic demand but still relies on imports for high-grade material.
The market anticipates continued volatility driven by bio-feedstock price cycles and global freight rates. Incremental increases in production technology efficiency could moderate extreme upward swings, but underlying costs remain tied to agricultural commodity dynamics. Regulatory tightening for food and pharma applications will likely widen the price differential between commodity feed grade and high-purity specialty lots. As suppliers invest in both scale and compliance systems, mid-decade pricing looks to hold at current gradients with a moderate upward slope unless major shocks occur in base crop markets or energy access.
All market trend analysis integrates published production statistics, major commodity indices for carbohydrate feedstocks, and ongoing customer demand signals from multi-year supply contracts. Forward-looking statements rely on internal records, customer engagement reports, and regional capacity expansion announcements verified by public filings and international trade monitoring services.
Continued investments in new fermentation reactor capacity have increased domestic self-sufficiency in several major consumption economies. Suppliers adapting to high-purity market demands invest in online analytics, reducing risk of out-of-spec batches. Key exporters respond to tightening animal feed import controls with updated batch documentation, standardized risk assessments, and third-party certifications.
Stricter cross-border labeling and batch traceability laws emerge from several food and pharma regulatory agencies affecting both on-site production recordkeeping and post-shipment surveillance. New maximum impurity limits for trace metals and allergens apply to pharmaceutical and infant nutrition applications, driving process purification upgrades and cross-contamination risk assessments during transport and storage.
Producers standardize process validation protocols to assure compliance with emerging global standards. Raw material trace documentation is upgraded, and supplier audits intensify to prevent adulterant introduction. Dedicated batch segregation for high-purity orders and investment in digital traceability improve responsiveness to customer and regulator queries. Production teams focus on batch-to-batch consistency, emphasizing rapid in-process monitoring and full-lot release clearance before shipment authorization.
L-Threonine production at the manufacturer level targets several key sectors. In animal nutrition, it serves as an essential amino acid for poultry, pigs, and aquaculture to balance diets and improve feed efficiency. In the food industry, L-Threonine helps formulate supplements and fortification blends, addressing both functional and nutritional needs. Pharmaceutical applications require L-Threonine as a component in parenteral and oral formulations, where purity, safety, and bioavailability directly affect compliance and clinical value.
For fermentation, biotechnology manufacturers require specific L-Threonine grades tailored to their yield optimization and contamination control strategies. Technical and specialty chemical applications can demand grades with non-standard impurity profiles or tailored particle characteristics. Cosmetic sectors use L-Threonine for its conditioning properties in skin and hair care formulas, where allergen and trace impurity control influence acceptance.
| Industry | Recommended L-Threonine Grade | Key Considerations |
|---|---|---|
| Feed | Feed Grade | Evaluates bioavailability, absence of prohibited substances, major elemental impurities, and processing aids derived from fermentation. Particle size distribution and mixing behavior are validated per feed blending needs. |
| Food & Beverage | Food Grade | Requires adherence to food additive codes, monitoring residual solvents and microbial profile. Heavy metals and allergen screening follow regionally relevant laws. If used in infant nutrition, stricter batch-release logic applies. |
| Pharmaceutical | Pharmaceutical Grade (e.g., USP, EP) | Audit trail for manufacturing, validated analytical testing against pharmacopoeia, low endotoxin, and thorough excipient compatibility studies. Process yields must account for sterility and pyrogen control beyond standard purity controls. |
| Biotechnology/Fermentation | Customized Technical Grade | Optimized for low bioburden, tailored for specific culture media. Impurity profile follows client-method transfer; batch-to-batch consistency and traceability are priorities. |
| Cosmetic | Cosmetic Grade | Follows IFRA/allergy guidelines, microbially safe, and produced using controlled process water quality. Fragrance residue and micro residuals are minimized during finishing. |
Each application sector assesses L-Threonine based on parameters relevant to its downstream risks and requirements. In feed use, the priority falls on digestibility, particle size, and extractable protein content as per animal science studies. Food applications emphasize total microbial count, heavy metal panel, and allergen residues, often paired with origin and raw material traceability. Pharmaceutical users require in-depth documentation covering synthesis, critical in-process checks, and certificate of analysis alignment to recognized monographs.
Cosmetic product grades get scrutinized for fragrance and allergen controls, whereas fermentation users pay close attention to bioburden, sterilant residuals, and lot-to-lot performance data. All users benefit from clear batch tracking, audit data, and quick response to technical support issues, typically managed via internal CAPA protocols.
Users must identify the end-use application as this affects the grade family under review. Feed, food, pharma, biotech, or specialty chemical applications each involve different risk control logic and specification focus. Experience shows that clearly classifying the intended use streamlines regulatory and analytical pathway discussions with suppliers.
Each region and sector uses its own code lists for amino acid additives. Food and pharma applications usually reference local and global standards (such as FCC, JECFA, USP, or EP). Feed users in various jurisdictions evaluate compliance with local positive lists and banned substance logs. Clients should map exact legal and self-regulatory demands before committing to a grade.
Not all L-Threonine grades are designed for the same purity. Feed grades control key impurities influencing palatability, while pharmaceutical and parenteral grades undergo enhanced screening for elemental and organic contaminants, backed by validated methods. Food users often request information on allergens or specific processing aids. If downstream sensitivities exist, clear communication with the manufacturer allows for batch-specific analytical backing.
Formulators and procurement need to match annual requirement forecasts to available supply chains and logistics arrangements. Large-volume users generally receive batch-specific support, with strict scheduling for bulk deliveries. Where volumes are small, or high grade is necessary, lead times and batch revalidation must be planned in advance, balancing cost with analytical requirements.
Before adoption, requesting a sample with full quality documentation lets downstream users validate compatibility, performance, and formulation. Internal testing can compare manufacturer batch records with end-use safety or verification checks, identifying any specification misalignments early. Manufacturers welcome collaborative trials that aid in tuning process or analytical parameters for future batches.
Maintaining consistent quality for L-Threonine production begins with a certified quality management system. Our plant operates under audit-backed quality management frameworks such as ISO standards, with external review intervals set to align with regulatory requirements and industry best practices. This forms the foundation for system-level controls: incoming raw materials, process monitoring, batch traceability, and deviation handling. ISO certification signals control maturity, but implementation details—internal audit cycles, corrective action effectiveness, the experience of QA personnel—carry substantial impact on actual batch reproducibility and reliable lot release.
Market-sensitive grades of L-Threonine, especially for food, feed, and pharma, demand proof documents tailored to regulatory and application norms. Kosher, Halal, and non-GMO certifications are common customer requirements, and are maintained as dictated by raw material origin and process chain integrity. For pharma-grade L-Threonine, GMP compliance and pharmacopeial testing documentation are provided when the product is destined for regulated drug synthesis or formulation. Certificate types offered—pharmaceutical, feed, or food—depend on the specification, and requests for customized documentation undergo review against batch production records and grade-specific validation.
Every shipment leaves with a certificate of analysis, backed by batch-level laboratory records. Reports typically summarize test methods relevant to the specification contracted: chiral purity, total assay, moisture, specific rotation, microbiological parameters for sensitive applications, and others as relevant. Technical dossiers can be prepared for regulatory submissions or customer registration programs. Access to production and quality records is determined by confidentiality policy, with scope and format shaped by the market sector: feed or food buyers expect streamlined documentation, while pharma clients may require audit rights, manufacturing process descriptions, and analytical method validation summaries.
Production scheduling for L-Threonine is built on predictable long-term demand and raw material supply contracts. Allocation logic follows a mix of annual off-take commitments, rolling forecasts, and spot volume flexibility for key accounts. For customers seeking assurance of continuity, outlook agreements and minimum volume reservations can anchor capacity over agreed periods. For more variable requirements or project-based needs, call-off arrangements, rapid-response spot orders, and split deliveries match operational realities. Production clusters and process route redundancy support supply security beyond single-point lines. Adjustments to lot size, shipment intervals, and incoterms are negotiable under a unified business development workflow, with an emphasis on advance coordination.
Facility infrastructure and process design are structured for multi-month campaign runs and large-lot output, supporting consistent quality and competitive throughput. Key control points include raw material stockholding, continuous fermentation process supervision, end-point analytics, and shift record maintenance. Process flexibility allows transition between grades as dictated by contract mixes—feed, food, or pharma—and secondary purification measures target impurity profiles according to downstream requirements. Batch release and delivery scheduling are managed through joint planning routines involving production, logistics, and sales support, ensuring on-time shipment and buffer inventory for higher reliability during seasonal demand spikes.
Technical and commercial departments handle sample requests through a controlled application protocol to match intended application and regulatory status. For new customer qualification, sample selection is based on the matching grade and typical batch trend, with supportive documentation reflecting the run history of the supplied lot. Application forms outline usage context, volume, and required tests. Coordination with the lab enables access to the most relevant batch records for customer evaluation, and technical support remains available during qualification trials. Minimum sample quantities and shipment modalities are defined per market sector and logistics feasibility.
Long-term contracts, spot purchase mechanisms, volume ramp-up programs, and joint R&D sourcing all fall within the available cooperation modes. Approach is determined by customer procurement models: strategic buyers with predictable projections typically lock in scheduled volume agreements; others may utilize framework agreements or rolling purchase forecasts to secure manufacturing slot flexibility. Specialty users requiring unique specifications or process adjustments enter co-development supply dialogues, integrating manufacturing process steps with downstream application trials. For markets emphasizing seasonal or regulatory volatility, multi-site production backup and specification adaption capability support business resilience and agility.
In recent process optimization, enzyme catalysis remains a major focal area for L-Threonine. Research labs and production engineers work on strain improvement of E. coli and Corynebacterium glutamicum to push conversion rates and minimize by-product formation. Systematic upgrades target metabolic pathway flux, gene regulation, and resistance to toxic intermediates. Reactor engineering, including fed-batch and continuous mode adjustment, sees tangible progress, driving cost per ton lower for feed grade material.
The market increasingly demands higher purity L-Threonine for emerging applications in animal feed, oral nutrient solutions, and parenteral nutrition. End users in the poultry and aquaculture sectors specify narrow impurity profiles and trace heavy metal limits. For pharmaceutical intermediate production, interest grows in L-Threonine as a chiral building block; these requirements shape purification process selection and the focus on close analytical quality management.
Consistent fermentation batch-to-batch remains critical, especially given variability in raw sugar sources and nutrient supplement variation. High-performance downstream purification, combining multiple crystallization passes and advanced chromatographic separation, delivers reproducibility but raises cost and water use. Recent breakthroughs adopt membrane filtration to achieve cost-effective decolorization and desalting, reducing solvent demand and liquid effluent loading. For certain grades, maintaining low endotoxin and bioburden levels requires both source control and stringent post-processing under clean conditions.
Global supply projections for L-Threonine align with continued growth in monogastric animal nutrition, especially as feed formulators substitute synthetic amino acids to optimize protein efficiency. Plant upgrades in Asia and Europe will boost output; price fluctuations will closely track fermentation feedstock cost and global logistics. The fastest expansion is seen in regions with evolving livestock industry standards and stricter feed formulation policies.
Fermentation technology continues its shift toward higher substrate conversion via metabolic engineering and automated process control. Digitalization allows real-time adjustment to keep process drift in check, helping manage yield and impurity generation. Next-generation plants invest in integrated utilities to recover and recycle process water and minimize thermal energy use. As synthetic biology advances, routes based on engineered microbial consortia could redefine cost and impurity profiles for future production.
Sustainability targets guide both raw material selection and waste management strategies. Sugar sourcing increasingly favors certified renewable origin and sustainable agriculture. Closed-loop water systems and valorization of fermentation by-products reduce environmental impact. Up-stream process intensification, lean solvent use, and valorization of mother liquors into bioenergy or fertilizer are under internal review to meet emerging regulatory and customer sustainability audits.
Direct technical support covers inquiries from feed millers, premix producers, and pharmaceutical companies. Our technical service team addresses questions regarding grade selection, compatibility with existing formulations, and impact of batch variability on end-user process yield. Consultation often involves breakdown of impurity profiles, color specifications, and microbial contamination risk relevant for application-critical users.
Site visits and process audits for key customers allow our engineers to observe how L-Threonine behaves during mixing, pelleting, and final application. Specific troubleshooting includes recommendations on micro-dosing, storage humidity management, and preventive measures to minimize caking or degradation. For injectable and high-purity applications, optimization focuses on minimization of particulate or pyrogen introduction during formulation.
Every shipment batch is accompanied by traceable analytical data, including release documentation derived from both batch control and final product testing. Customer complaints trigger root cause investigation, spanning from process raw material review to logistics scrutiny. Continuous engagement post-sale ensures feedback channels remain active, supporting quality improvement cycles and enabling tailored support to evolving customer standards and specifications.
In our L-Threonine plant, production starts with fermentation using refined inputs, monitored throughout by our in-house technical team. Handling core steps such as isolation and crystallization, we manage process consistency batch after batch. Our reactors, filtration systems, and drying facilities receive regular calibration and preventive maintenance to minimize process deviation. Operators keep detailed records at each critical control point, documenting fermentation conditions, harvest yields, and purity outcomes as verified by our quality laboratory. This hands-on approach to processing supports a high degree of lot-to-lot reliability, directly controlled in our own manufacturing space.
Commercial nutrition producers use our L-Threonine to balance essential amino acid profiles in compound feeds. Integrated feed mills and independent premix blenders both depend on accurate inclusion rates, which requires precise assay values and controlled impurity levels. In wet and dry feed formats, our L-Threonine supports efficient protein formulation for livestock, poultry, and aquaculture. We also supply to food ingredient processors and select technical grade users that demand stringent contaminant monitoring, such as those making fermentation media and specialty biochemicals.
Every batch undergoes final analysis in our on-site lab, using instruments calibrated against industry standards for amino acid content, moisture, and heavy metals. Retained samples from each lot give us traceability through the supply chain. We maintain documentation showing analytical consistency across repeated production cycles and respond to customer requirements for supporting certificates or detailed product history. Internal traceability and data-driven process improvements form the core of our ongoing investment in quality.
We invest in automated packaging lines to fill and seal L-Threonine in multiple formats, including 25 kg bags, jumbo bags, and bulk containers for direct plant delivery. Every unit receives a lot label and is shrink-wrapped or palletized in our own logistics facility. Seasonal demand spikes and contract shipment schedules shape our inventory strategy, with a distribution center near major ports for international orders. We run our own dispatch and delivery planning, not relying on third parties for order consolidation or short-term sourcing.
Our technical and logistics specialists work directly with feed formulators, nutritionists, and purchasing managers seeking updates on product specifications, mixing practices, and compatibility with automated dosing systems. Our team designs tailored supply solutions for regular industrial consumption and is available for troubleshooting during feed mill trial runs or process audits. We provide documentation on shelf life, storage conditions, and application methods for each shipment.
Consistent base material supports leaner inventory management and reduced formulation adjustments at the customer’s facility. Manufacturers, distributors, and bulk ingredient buyers come to us for predictable lead times and the ability to secure contractual product flows tied to their production schedules. Our vertically integrated operation allows us to accommodate special handling requests and respond rapidly to demand changes without supply interruptions. Strong batch integrity and technical responsiveness help our partners control risk and meet deliverable timelines in their production environments.
| Production Control | Industrial Focus | Technical Support | Supply Flexibility |
|---|---|---|---|
| In-house fermentation and processing | Animal nutrition and technical processing | Direct troubleshooting and process guidance | Automated packaging, multiple logistics options |
| Lot-level traceability and testing | Controlled impurity and moisture standards | Custom response to application issues | Inventory planned to match customer demand |
Our day-to-day work in L-Threonine production centers on direct process responsibility, measurable product quality, and reliable industrial partnership. These strengths define our value as a manufacturer serving business buyers requiring long-term technical and commercial support.
As the manufacturer producing L-Threonine at scale, we fully understand that consistent quality and purity drive the confidence our clients place in our ingredient. In feed, food, or pharmaceutical sectors, the bottom line always reflects the reliability of raw materials, especially amino acids like L-Threonine.
Our customers count on a minimum purity standard. For L-Threonine, we routinely guarantee not less than 98.5% (on dry basis) purity by HPLC. We do not just set that as a paperwork specification—our core processes and quality systems are engineered to achieve, verify, and sustain that figure. Purity at this level ensures the functional performance of L-Threonine in nutritional formulations is uncompromised. The finished product does not face unpredictability from side impurities or excessive loss from lower assay.
High-purity L-Threonine protects against off-note odors, color shifts, or foreign materials during production and storage. Impurities may come from fermentation by-products, raw materials, or even unintended process variations. We address these risks in our factory by selecting robust fermentation strains and maintaining downstream purification standards with both efficiency and consistency.
While our certificate of analysis will always reflect not less than 98.5% purity, customers usually see actual assay values in the range of 99.0% to 99.5% L-Threonine on delivered lots. Our internal release criteria—built around process capability—keep values solidly above the minimum and minimize batch-to-batch drift. Every batch is subjected to validated HPLC testing before leaving our plant, matching strict QC protocols. Our QC laboratory regularly cross-validates tests with external laboratories to reinforce accuracy.
The result for customers: real-world assay values support tighter blending, more reliable dosing, and compliance with both global and local regulatory standards. Nutritionists and formulators do not need to carry heavy overage factors, which translates into better economics for end-users and stronger performance in feed or food applications.
We have invested heavily in monitoring and optimizing fermentation and separation environments. Every input is subject to supplier qualification and analytical screening: starting with raw sugars, through nutrients and seed cultures. Purification steps—like ion-exchange, filtration, and spray-drying—are designed to maximize yield while filtering out residuals. Our technical team is hands-on during every stage, using preventive maintenance and real-time analytics to keep systems running clean.
Finished goods are tested not just for L-Threonine assay, but for related amino acids, moisture, ash, and microbial contaminants. Microbial control receives particular attention since L-Threonine is highly sensitive to poor sanitation. Monthly audits, plus regular training for operators, keep all key checkpoints sharp.
We recognize that many customers need ongoing documentation for audits or regulatory review. Our technical team can provide complete batch traceability, method validation, and test data, including recent third-party verifications as requested. Meeting purity means more than a number—it is a reflection of robust plant operations and a mindset of consistency.
Direct-from-factory quality assurance holds real value only if the commitment shows in every delivery and in our everyday business practices. We believe in building trust through transparent, measurable, and verifiable quality of our L-Threonine product, batch after batch.
Our teams handle L-Threonine production daily, so the question of minimum order quantity comes up often, especially from partners scaling up. As a direct manufacturer operating bulk fermentation plants, we need to structure manufacturing to balance both efficiency and consistency.
Batch planning in our facilities runs based on fermenter capacity and downstream processing loads. Shipping out single small lots disrupts line balance, especially for a widely used animal feed amino acid. We set our MOQ at the factory packing level—typically a full pallet equals 850–1,000 kg, sealed in 25 kg kraft paper bags with PE liners. This keeps the product stable from our loading docks through ocean shipment to offloading in customers’ blenders or warehouses. Handling in pallet lots also minimizes contamination risk. Smaller quantities can be arranged but require custom handling and surge unit costs.
Since we control every stage from fermentation to final packing, our promise isn’t based on an import agent’s inventory—every ton that ships comes straight from our production lines. For contract partners and ongoing customers, we plan monthly according to annual forecast, so just-in-time (JIT) deliveries can move straight from plant to port. Spot orders that fit inside a current batch can leave inside a week, but if production lines are at capacity or if special grade specification calls for new validation, expect three to four weeks from order to container terminal. Holiday surges and periodic maintenance shutdowns can add time in the range of several days.
Our technical teams watch over fermentation, crystallization, and drying steps to keep output in perfect spec. Unplanned stoppages may arise from local infrastructure, energy, or logistics disruptions. As a manufacturer, we can pivot production schedules if a customer faces urgent need; air shipments or partial-batch allocation are solutions we have offered during agricultural disease outbreaks and peak season spikes. Transparent manufacturing data, daily output logs, and safety stock buffers are part of our proactive planning.
As soon as finished L-Threonine leaves our on-site QA lab, our warehouse dispatch coordinates with forwarders familiar with feed-grade and pharma-grade handling. Sea freight to many main ports from our East Asia complexes runs about four to five weeks, factoring in customs and inland haulage. For orders headed toward remote blending facilities, we can coordinate with customers for cross-docking or last-mile transfer on secure, dry trailers.
Global amino acid feed cycles face pricing and availability tension, especially whenever upstream input prices shift. Communication between our scheduling office and customer planners helps everyone stay ahead of potential bottlenecks. We always recommend customers share as much forecast visibility as possible, even for spot business. As a bulk producer, we hold a responsibility to control cost and quality together—order sizes and lead times reflect both process realities in the plant and pragmatic market experience.
Producing L-Threonine carries a clear responsibility: meeting and documenting compliance with the demands of authorities such as the FDA and REACH. These rules stretch from raw material sourcing right through to final shipment. We do not cut corners, whether for applications in food, feed, or pharmaceuticals. Each production batch undergoes thorough testing in our in-house quality labs, aligning with internationally accepted standards. This step supports the traceability and reliability clients expect in regulated supply chains.
Customers often require immediate access to a Certificate of Analysis and Safety Data Sheet with every shipment. We generate these documents for each production lot. The COA reflects actual test results from our accredited laboratory and shows compliance with established specifications. The SDS comes updated to reflect current chemical regulations, including hazard communication protocols in different markets. Such documentation is not an afterthought. It starts at raw material inspection and follows through to packing and delivery.
Compliance does not stop with a checklist. Our facility operates on systems that have stood up to inspections by both local and global regulators. We employ software that tracks every key parameter, from fermentation to drying, so every lot of L-Threonine can be traced back to the exact conditions under which it was manufactured. Auditors—whether representing our own QA team or outside bodies—can access every record, because we recognize that transparency builds trust. That same traceability lets us act quickly in the rare event of a deviation, limiting risks and supporting customer confidence.
Shipments destined for Europe receive full REACH compliance documentation. For US customers, our team follows the current FDA food and feed additive guidelines. This means adhering to strict limits on known impurities and reporting any changes in process or raw material sources. Our documentation aligns with the latest legal amendments and can be provided in multiple formats as required for local registration or import customs.
Market requirements change, and regulatory standards evolve. We watch these developments closely and adapt our own processes ahead of time. Our technical team remains in contact with regulators, trade associations, and certification bodies to anticipate upcoming changes. This proactive stance means our L-Threonine remains compliant even as rules shift. Clients benefit from uninterrupted supply and advance notice of any changes that could affect downstream approvals.
Our production facilities are open to customer audits and quality inspections. We welcome technical discussions about best practices and regulatory compliance. Meeting a country's registration or import requirements is a team effort, and we take that commitment seriously. If you need additional documentation or detailed breakdowns of our quality controls, our technical support is ready to provide clear evidence of our compliance. L-Threonine leaves our factory not just as a product, but as a promise backed up by data, documentation, and experience.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
